Real-time Estimate
Other stock markets
|
||
96.86 CHF | 0.00% |
|
04:05pm | Amneal Pharmaceuticals to Develop Omalizumab Biosimilar for Allergy Treatments | MT |
01:00pm | New semester, new state of mind | ![]() |
Official Publications
- Stock Market
- Equities
- NOVN Stock
- Stock
- News Novartis AG
- Official Publications